LLY vs UNH
By Alex · Tickerpine
Eli Lilly and Company vs UnitedHealth Group Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | UNH |
|---|---|---|
| Price | $1,273.46 | $418.09 |
| Market cap | $1.14T | $375.28B |
| P/E ratio | 42.7 | 26.9 |
| ROE | 102.29% | 15.77% |
| Profit margin | 33.53% | 3.53% |
| Revenue growth | 47.70% | -0.40% |
| Dividend yield | 0.54% | 2.22% |
| Beta | 0.45 | 0.61 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs UNH in plain English
- LLY is the bigger company — about 3.0× the market cap of UNH.
- UNH is cheaper on earnings (P/E 26.9 vs 42.7).
- LLY earns a higher return on equity (102% vs 16%).
- LLY is growing revenue faster (48% vs -0%).
- UNH has the higher dividend yield (2.22% vs 0.54%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.